| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8819876 | Respiratory Medicine | 2018 | 5 Pages |
Abstract
Our data suggest that anti-MDA5-positive patients with CADM who also have MAAs have a better prognosis than those without MAAs; thus, anti-MDA5 autoantibodies by themselves may not be strong predictors of worse clinical outcomes in patients with CADM. Coexistent MAAs could be biomarkers for a favorable prognosis in anti-MDA5-positive patients with CADM.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Koichi Yamaguchi, Aya Yamaguchi, Chiharu Kashiwagi, Yuri Sawada, Kohei Taguchi, Kazue Umetsu, Kazuma Oshima, Megumi Uchida, Masafumi Suzuki, Shunichi Kono, Masao Takemura, Hiroaki Masubuchi, Shinsuke Kitahara, Kenichiro Hara, Toshitaka Maeno,